Trial Profile
Exploratory Phase II Study of KRP-203 -A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of KRP-203 in Patients with Crohn's Disease in Active Phase-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Mocravimod (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 25 May 2016 New trial record